Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. Stephen Finn

Associate Professor Consultant (Histopathology)
SIR PATRICK DUN LAB


Dr. Stephen Finn MB BAO BCh FDS PhD FRCPath FFPATH, is a Associate Professor, Consultant Pathologist and Principal Investigator at The University of Dublin, Trinity College and at St. James's Hospital Dublin, a tertiary referral cancer institution. He is co-director of the Cancer Molecular Diagnostic Laboratory, the only fully accredited molecular diagnostic laboratory in Ireland. His clinical practice is limited to Urological, Gastrointestinal and Liver pathology. Dr. Finn is former Senior Scientist and Staff Pathologist to the Centre for Molecular Oncologic Pathology at the Dana Farber Cancer Institute, Boston, USA. Dr. Finn continues to have strong personal and collaborative links to the Harvard School of Public Health, the Dana Farber Cancer Institute and the University of Orebro in Sweden. Dr. Finn is a member of the Irish Prostate Cancer Research Consortium (PCRC) and the Transdisciplinary Prostate Cancer Partnership ToPCaP. Dr. Finn, a current recipient of the Prostate Cancer Foundation Young investigator Award, and is committed to forging a career as an independent researcher focused on prostate cancer and bringing his skills as a clinician, pathologist and scientist to bear on critical questions of clinical relevance to men who suffer from aggressive prostate cancer.
  ARCHIVAL MATERIAL   BETA-CATENIN   Cancer Molecular Diagnostics   Cancer/Carcinogenesis   CATENIN COMPLEX   Diagnostic bioimaging   DIAGNOSTIC LABORATORIES   DIGESTIVE TRACTS   DISSECTION   E-CADHERIN   EPITHELIAL-CELLS   FROZEN SECTION   GASTRIC CARCINOMAS   GENE   H4 D10S170   HASHIMOTO THYROIDITIS   HEAD AND NECK CANCER   Imaging Techniques   Lipid metabolism   Lung Cancer   NECK DISSECTION   Obesity   ORAL CAVITY   PAPILLARY THYROID CARCINOMA   Pathology   PATTERNS   Prostate cancer   RATIONALE   RET PROTOONCOGENE   RET/PTC-1   SQUAMOUS-CELL-CARCINOMA   STAGING   STAGING PROCEDURE   TAQMAN RT-PCR   TYROSINE PHOSPHORYLATION
 Identifying non-coding RNA repertoires of aggressive Prostate cancer
 EXPECT Trial: Evasion of immune editing by circulating tumour cells is an exercise-modifiable mechanism underlying aggressive behaviour in obese men with prostate cancer
 Discovery and Clinical Implementation of Novel Predictive Biomarkers for Enzalutamide therapy

Details Date
Chairman Molecular Pathology, Faculty of Pathology, RCPI 01/02/2011
Details Date From Date To
Fellow of the Royal College of Pathologists 2005 Current
O'Brien O, Wright MC, O'Brien C, Geoghegan O, Leonard N, Nicholson S, Cuffe S, Fabre A, Jochum W, Joerger M, Gray SG, Finn SP., Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples., Diagnostics (Basel), 9, (1), 2019, Journal Article, PUBLISHED  DOI
John Aird, Anne-Marie Baird, Marvin C.J. Lim, Ray McDermott, Stephen P. Finn, Steven G. Gray, Carcinogenesis in prostate cancer: The role of long non-coding RNAs, Non-coding RNA Research, 3, (1), 2018, p29--38 , Journal Article, PUBLISHED
Konrad H. Stopsack, Amparo G. Gonzalez-Feliciano, Samuel F. Peisch, Mary K. Downer, Riley A. Gage, Stephen Finn, Rosina T. Lis, Rebecca E. Graff, Andreas Pettersson, Claire H. Pernar, Massimo Loda, Philip W. Kantoff, Thomas U. Ahearn, Lorelei A. Mucci, A Prospective Study of Aspirin Use and Prostate Cancer Risk by TMPRSS2:ERG Status, Cancer Epidemiology Biomarkers & Prevention, 2018, pcebp.0510.2018 , Journal Article, PUBLISHED
Rulle U, Tsourti Z, Casanova R, Deml KF, Verbeken E, Thunnissen E, Warth A, Cheney R, Sejda A, Speel EJ, Madsen LB, Nonaka D, Navarro A, Sansano I, Marchetti A, Finn SP, Monkhorst K, Kerr KM, Haberecker M, Wu C, Zygoura P, Kammler R, Geiger T, Gendreau S, Schulze K, Vrugt B, Wild P, Moch H, Weder W, Ciftlik AT, Dafni U, Peters S, Bubendorf L, Stahel RA, Soltermann A., Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort., Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 13, (12), 2018, p1851-1863 , Journal Article, PUBLISHED  DOI
Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA., A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG., European urology, 2018, Journal Article, PUBLISHED  DOI
MacDonagh, L. and Gray, S.G. and Breen, E. and Cuffe, S. and Finn, S.P. and O'Byrne, K.J. and Barr, M.P., BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC, Cancer Letters, 428, 2018, p117-126 , Notes: [cited By 0], Journal Article, PUBLISHED  DOI
Newton RU, Kenfield SA, Hart NH, Chan JM, Courneya KS, Catto J, Finn SP, Greenwood R, Hughes DC, Mucci L, Plymate SR, Praet SFE, Guinan EM, Van Blarigan EL, Casey O, Buzza M, Gledhill S, Zhang L, Galvão DA, Ryan CJ, Saad F., Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol., BMJ Open, 8, (5), 2018, Journal Article, PUBLISHED  DOI
Lim MCJ, Baird AM, Aird J, Greene J, Kapoor D, Gray SG, McDermott R, Finn SP., RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer-From Cell Line Models to Liquid Biopsies., Diagnostics (Basel), 8, (3), 2018, Journal Article, PUBLISHED  DOI
Kerr KM, Dafni U, Schulze K, Thunnissen E, Bubendorf L, Hager H, Finn S, Biernat W, Vliegen L, Losa JH, Marchetti A, Cheney R, Warth A, Speel EJ, Blackhall F, Monkhorst K, Jantus Lewintre E, Tischler V, Clark C, Bertran-Alamillo J, Meldgaard P, Gately K, Wrona A, Vandenberghe P, Felip E, De Luca G, Savic S, Muley T, Smit EF, Dingemans AC, Priest L, Baas P, Camps C, Weder W, Polydoropoulou V, Geiger TR, Kammler R, Sumiyoshi T, Molina MA, Shames DS, Stahel RA, Peters S, ETOP Lungscape Consortium., Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project., Annals of oncology : official journal of the European Society for Medical Oncology, 29, (1), 2018, p200-208 , Journal Article, PUBLISHED  DOI
Heavey S, Dowling P, Moore G, Barr MP, Kelly N, Maher SG, Cuffe S, Finn SP, O'Byrne KJ, Gately K., Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines., Scientific Reports, 8, (1), 2018, p1652-, Journal Article, PUBLISHED  TARA - Full Text  DOI
  

Page 1 of 14